Advanced Intake
Multi-channel intake solution for safety and quality data
Software · Cloud SaaSCompany source
Company profile
About ArisGlobal
ArisGlobal is a leading provider of AI-powered life sciences software solutions trusted by over 220 pharmaceutical companies and health agencies worldwide. The company's flagship LifeSphere platform delivers comprehensive, interoperable solutions across Safety (pharmacovigilance), Regulatory, Quality Management, and Medical Affairs. ArisGlobal's technology transforms fragmented R&D ecosystems into unified, AI-powered, decision-intelligent enterprises. The LifeSphere platform includes specialized modules: LifeSphere Safety for unified pharmacovigilance with touchless case processing; LifeSphere Regulatory for end-to-end regulatory lifecycle management including RIM, submissions, labeling, and compliance; LifeSphere Quality for quality management and documentation; and LifeSphere Medical Affairs for seamless information flow and automation. The platform is embedded with next-generation technologies including advanced GenAI features through NavaX, ArisGlobal's agentic AI solution. NavaX represents ArisGlobal's enterprise-scale AI offering, featuring specialized agents for MedDRA coding, signal detection, distribution, and regulatory intelligence. The company also offers SPORIFY for SPOR and ISO IDMP compliance, and XDI for data integration. ArisGlobal serves enterprise pharmaceutical companies, small to medium pharma, and contract research organizations (CROs), providing both SaaS platforms and consulting services to operationalize AI at scale across the drug development lifecycle.
Company description ArisGlobal official website
Primary marketDrug Discovery & Development
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at ArisGlobal?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Contract Research Organizations (CROs)
- Enterprise pharmaceutical companies
- Health agencies
- Small to medium pharma
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsGlobal
Company sourceOfficial website
Company milestones
Platform expansion
Launch of ReporterX for advanced case reporting; Breakthrough 2026 conference held; NavaX agentic AI platform launched with specialized agents for safety and regulatory; SPORIFY launched for SPOR and ISO IDMP compliance
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Advanced Signals
AI-powered signal detection and risk management for pharmacovigilance
Software · Cloud SaaSCompany source
LifeSphere Medical Affairs
Seamless information flow and automation across Medical Affairs and Safety operations
Platform · Cloud SaaSCompany source
LifeSphere Quality
Complete quality management and documentation solution for life sciences R&D and manufacturing
Platform · Cloud SaaSCompany source
LifeSphere Regulatory
End-to-end regulatory lifecycle management platform with embedded AI technologies
Platform · Cloud SaaSCompany source
LifeSphere Safety
Unified, next-generation SaaS safety platform for touchless case processing and global pharmacovigilance
Platform · Cloud SaaSCompany source
Literature Intelligence
Automated literature monitoring and case extraction for pharmacovigilance
Software · Cloud SaaSCompany source
MultiVigilance
Comprehensive pharmacovigilance case management solution
Software · Cloud SaaSCompany source
NavaX
AI-first platform for operationalizing AI at enterprise scale in life sciences R&D
Platform · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Touchless case processing
Pharmacovigilance automation
Scalable compliance
Global pharmacovigilance workflows
Significant efficiency gains
Medical Affairs and Safety automation
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from ArisGlobal
Recent articles published on ArisGlobal's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Drug Discovery & Development
Companies using AI, machine learning, or computational biology to discover new drug candidates, identify drug targets, predict drug efficacy, or accelerate pharmaceutical development. Includes both small molecule and biologics development, precision oncology drug discovery, and AI-driven target identification and molecule design.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.